On Sep. 9, 2018, the FDA released a Final Guidance regarding the use of product identifiers on packages and homogenous cases of product as mentioned in the Drug Supply Chain Security Act (DSCSA).
The practice of compounding medicines can provide important public health opportunities. The FDA’s compounding program – including implementation of the compounding provisions of the law – is a priority for the agency. We recognize that in delivering on implementation commitments, we must balance the need to preserve[...]
We want to thank everybody who came to visit our booth at this year’s ASHP Summer Meetings & Exhibition.
ConsortiEX™, a Milwaukee-based pharmacy IT software and services company, is pleased to announce the addition of our newest Advisory Board member, Mick Hunt. Mr. Hunt has a long career in pharmacy administration and education, and is noted for his role in the adoption of key advancements in pharmacy practice and[...]
Today, hospital pharmacies and outsourcing facilities are striving to optimize process efficiency while maintaining rigorous patient safety standards. But many in the industry are finding it difficult to make this mission-critical goal a reality.
Guest post from Children’s Hospital of WI
For hospital pharmacies and outsourcing facilities, patient safety is a primary driver. Today, it takes on added significance as facilities wrestle with meeting DQSA and DSCSA compliance mandates. As a result, many in the industry are turning to enterprise resource planning (ERP) to address their needs. But they are[...]
We recently sat down with ConsortiEX CEO, Neal Long, to discuss the company’s background and learn more about its plans to help hospitals safely distribute, source and track compounded pharmaceuticals among affiliated hospitals. addresses the worldwide problem of drug availability, patient safety and high costs. The[...]